# Biomage

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biomage

- Industry: Biotechnology
- Headquarters: Edinburgh, UK
- Website: www.biomage.net
- Total disclosed funding: $1.5M
- Latest round: Seed (Jan 1, 2021)
- Investors on record: 3

## About

Based in Edinburgh, UK, and founded in 2019 by CEO Adam Kurkiewicz, Iva Babukova, Vicky Morrison, and Peter Kharchenko, Biomage Limited, a.k.a. Biomage operates as a biotechnology research company that engages in biomedical data analysis for researchers to visualize individual cells's gene activity. In January 2024, Parse Biosciences, Inc., a portfolio company of Marshall Wace, Janus Henderson Investors, Logos Capital, Marshall Wace, Bioeconomy Capital, Soleus Capital Management, and Saras Capital, acquired Biomage, Limited from Luminous Ventures, SOSV, and IndieBio.

Biomage offers Cellenics®, an open-source software tool for analyzing single-cell RNA sequencing data. Cellenics® enables users to process, explore, and visualize their data from count matrices to publication-ready figures. The platform supports both local and systemic deployment and integrates with existing data storage and pipelining tools.

## Funding rounds

- Seed, Jan 1, 2021, $1.2M — SOSV, IndieBio, Luminous Ventures
- Seed, May 5, 2020, $0.3M — SOSV, IndieBio

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed
- IndieBio (https://capitalatlas.ai/funds/indiebio) — Seed
- Luminous Ventures — Seed